Streetbeat News

Stock Prices

FRO

Frontline (NYSE:FRO) reported Q3 adjusted EPS of $0.36, missing the $0.45 estimate, while sales of $377.08M exceeded the $249.41M estimate. Year-over-year, EPS decreased by 2.7%, and sales saw a slight decline of 1.33%.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:36 am

VLTO

Veralto (NYSE:VLTO) has advised its shareholders to reject TRC Capital's mini-tender offer to buy up to 2 million shares at $65.40 each, a 4.33% discount to the closing price on October 30, 2023. Veralto's stock closed at $73.32 on November 28, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:20 am

CBRL

DELL

KR

LZB

NTNX

U.S. stock futures are trading higher, with investor focus on earnings reports from The Kroger Co. (KR), La-Z-Boy Incorporated (LZB), Dell Technologies Inc. (DELL), Nutanix, Inc. (NTNX), and Cracker Barrel Old Country Store, Inc. (CBRL). Kroger is expected to report earnings of $0.90 per share on revenue of $33.91 billion. La-Z-Boy reported higher earnings and increased its dividend by 10%, with shares rising 2.5%. Dell is anticipated to post earnings of $1.46 per share on revenue of $23.02 billion. Nutanix reported better-than-expected results and raised its FY24 revenue guidance, leading to an 8.5% share increase. Cracker Barrel is expected to report earnings of $0.75 per share on revenue of $826.21 million.

Portfolio Pulse from Lisa Levin

November 30, 2023 | 7:19 am

CBRL

Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) is expected to report lower earnings for Q1 fiscal year ended Oct. 27, 2023, with analysts predicting earnings of 75 cents per share compared to 99 cents per share a year ago. Revenue is anticipated to be $826.21 million. The company outperformed expectations in Q4. Ahead of the earnings call, several analysts have revised their ratings and price targets for CBRL. Citigroup, Loop Capital, Truist Securities, UBS, and Piper Sandler have all provided updates, with price targets ranging from $66 to $96.

Portfolio Pulse from Lisa Levin

November 30, 2023 | 7:17 am

MEDS

TRxADE Health has received a notice from Nasdaq for not complying with the listing rules due to a delay in filing its quarterly report (Form 10-Q). The company has 60 days to submit a plan to regain compliance and may receive up to 180 days from the original due date to file the report and comply with Nasdaq's rules. TRxADE Health is working to complete and file the Form 10-Q as soon as possible.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 6:56 am

ATRA

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) announced positive new data for tabelecleucel (tab-cel®) in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease involving the CNS. The data, which will be presented at the ESMO Immuno-Oncology Congress, shows a 77.8% Objective Response Rate in 18 patients. This pooled analysis includes data from the Phase 2 EBVision Trial and is consistent with previous experiences.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 6:53 am

YI

111 Inc. (NASDAQ:YI) reported a Q3 EPS loss of $(0.12), a 20% increase in losses compared to $(0.10) per share YoY. However, sales rose to $502.40M, a 6.72% increase from $470.75M YoY.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 6:46 am

TSLA

Tesla's VP of Vehicle Engineering, Lars Moravy, has assured that all Tesla vehicles have brake disks designed to withstand extreme winter corrosion. Tesla employs a program that periodically engages brakes to prevent rust and uses Ferritic Nitro-Carburized rotors on Model 3 and Y for better corrosion resistance. However, concerns have been raised about Tesla's Full Self-Driving (FSD) Beta's performance in snowy conditions, with a user video showing the system struggling, leading to driver interventions.

Portfolio Pulse from Anan Ashraf

November 30, 2023 | 6:42 am

YY

JOYY Inc. (NASDAQ:YY) exceeded Q3 earnings and sales estimates with an adjusted EPS of $1.22, surpassing the $0.69 forecast by 76.81%, and sales of $567.10M, beating the $560.56M estimate by 1.17%. This reflects a 27.08% increase in EPS from last year, despite a 3.35% decrease in sales from the same period.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 6:32 am

BNR

Burning Rock Biotech reported Q3 earnings with a reduced loss per share of $(0.23), improving from $(0.31) YoY. However, sales declined to $17.48M from $21.74M YoY, marking a 19.56% decrease.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 6:29 am